BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 24457235)

  • 21. Socioeconomic disparities in immunotherapy use among advanced-stage non-small cell lung cancer patients: analysis of the National Cancer Database.
    Gupta A; Omeogu C; Islam JY; Joshi A; Zhang D; Braithwaite D; Karanth SD; Tailor TD; Clarke JM; Akinyemiju T
    Sci Rep; 2023 May; 13(1):8190. PubMed ID: 37210410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lung Cancer Mortality in the United States between 1999 and 2019: An Observational Analysis of Disparities by Sex and Race.
    Al Omari O; Jani C; Ahmed A; Singh H; Radwan A; Bhatt P; Walker A; Agarwal L; Goodall R; Shalhoub J; Marshall DC; Thomson CC; Salciccioli JD; Tapan U
    Ann Am Thorac Soc; 2023 Apr; 20(4):612-616. PubMed ID: 36476451
    [No Abstract]   [Full Text] [Related]  

  • 23. Racial disparities in histological subtype, stage, tumor grade and cancer-specific survival in lung cancer.
    Zeng H; Yuan Z; Zhang G; Li W; Guo L; Li N; Xue Q; Tan F
    Transl Lung Cancer Res; 2022 Jul; 11(7):1348-1358. PubMed ID: 35958334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of area-level socioeconomic status and non-small cell lung cancer stage by race/ethnicity and health care-level factors: Analysis of the National Cancer Database.
    Gupta A; Omeogu CH; Islam JY; Joshi AR; Akinyemiju TF
    Cancer; 2022 Aug; 128(16):3099-3108. PubMed ID: 35719098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of Obesity With Survival Outcomes in Patients With Cancer: A Systematic Review and Meta-analysis.
    Petrelli F; Cortellini A; Indini A; Tomasello G; Ghidini M; Nigro O; Salati M; Dottorini L; Iaculli A; Varricchio A; Rampulla V; Barni S; Cabiddu M; Bossi A; Ghidini A; Zaniboni A
    JAMA Netw Open; 2021 Mar; 4(3):e213520. PubMed ID: 33779745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Baseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation.
    Cortellini A; Ricciuti B; Tiseo M; Bria E; Banna GL; Aerts JG; Barbieri F; Giusti R; Cortinovis DL; Migliorino MR; Catino A; Passiglia F; Torniai M; Morabito A; Genova C; Mazzoni F; Di Noia V; Signorelli D; Gelibter A; Occhipinti MA; Rastelli F; Chiari R; Rocco D; Inno A; De Tursi M; Di Marino P; Mansueto G; Zoratto F; Grossi F; Filetti M; Pizzutilo P; Russano M; Citarella F; Cantini L; Targato G; Nigro O; Ferrara MG; Buti S; Scodes S; Landi L; Guaitoli G; Della Gravara L; Tabbò F; Ricciardi S; De Toma A; Friedlaender A; Petrelli F; Addeo A; Porzio G; Ficorella C
    J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33077515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Racial Disparities in Lung Cancer Survival: The Contribution of Stage, Treatment, and Ancestry.
    Jones CC; Mercaldo SF; Blume JD; Wenzlaff AS; Schwartz AG; Chen H; Deppen SA; Bush WS; Crawford DC; Chanock SJ; Blot WJ; Grogan EL; Aldrich MC
    J Thorac Oncol; 2018 Oct; 13(10):1464-1473. PubMed ID: 29885480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Whole body metabolic tumor volume is a prognostic marker in patients with newly diagnosed stage 3B non-small cell lung cancer, confirmed with external validation.
    Dashevsky BZ; Zhang C; Yan L; Yuan C; Xiong L; Liu Y; Liu H; Kong FS; Pu Y
    Eur J Hybrid Imaging; 2017; 1(1):8. PubMed ID: 29782599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic variation in the eicosanoid pathway is associated with non-small-cell lung cancer (NSCLC) survival.
    Sausville LN; Jones CC; Aldrich MC; Blot WJ; Pozzi A; Williams SM
    PLoS One; 2017; 12(7):e0180471. PubMed ID: 28704416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Body mass index and mortality in lung cancer patients: a systematic review and meta-analysis.
    Wang J; Xu H; Zhou S; Wang D; Zhu L; Hou J; Tang J; Zhao J; Zhong S
    Eur J Clin Nutr; 2018 Jan; 72(1):4-17. PubMed ID: 28513621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Marital status is an independent prognostic factor for tracheal cancer patients: an analysis of the SEER database.
    Li M; Dai CY; Wang YN; Chen T; Wang L; Yang P; Xie D; Mao R; Chen C
    Oncotarget; 2016 Nov; 7(47):77152-77162. PubMed ID: 27780931
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Racial and Gender Disparities in Incidence of Lung and Bronchus Cancer in the United States: A Longitudinal Analysis.
    Tabatabai MA; Kengwoung-Keumo JJ; Oates GR; Guemmegne JT; Akinlawon A; Ekadi G; Fouad MN; Singh KP
    PLoS One; 2016; 11(9):e0162949. PubMed ID: 27685944
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lung cancer incidence and mortality in China, 2010.
    Zheng R; Zeng H; Zhang S; Fan Y; Qiao Y; Zhou Q; Chen W
    Thorac Cancer; 2014 Jul; 5(4):330-6. PubMed ID: 26763691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Socioeconomic risk factors for long-term mortality after pulmonary resection for lung cancer: an analysis of more than 90,000 patients from the National Cancer Data Base.
    Khullar OV; Gillespie T; Nickleach DC; Liu Y; Higgins K; Ramalingam S; Lipscomb J; Fernandez FG
    J Am Coll Surg; 2015 Feb; 220(2):156-168.e4. PubMed ID: 25488349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stage-adjusted lung cancer survival does not differ between low-income Blacks and Whites.
    Aldrich MC; Grogan EL; Munro HM; Signorello LB; Blot WJ
    J Thorac Oncol; 2013 Oct; 8(10):1248-54. PubMed ID: 24457235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hispanics/Latinos in the Bronx Have Improved Survival in Non-Small Cell Lung Cancer Compared with Non-Hispanic Whites.
    Klugman M; Xue X; Ginsberg M; Cheng H; Rohan T; Hosgood HD
    J Racial Ethn Health Disparities; 2020 Apr; 7(2):316-326. PubMed ID: 31713221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lung cancer risk among smokers of menthol cigarettes.
    Blot WJ; Cohen SS; Aldrich M; McLaughlin JK; Hargreaves MK; Signorello LB
    J Natl Cancer Inst; 2011 May; 103(10):810-6. PubMed ID: 21436064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Determinants of black/white differences in colon cancer survival.
    Mayberry RM; Coates RJ; Hill HA; Click LA; Chen VW; Austin DF; Redmond CK; Fenoglio-Preiser CM; Hunter CP; Haynes MA
    J Natl Cancer Inst; 1995 Nov; 87(22):1686-93. PubMed ID: 7473817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
    Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
    Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.